US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myers

15.63

+0.58003.85%

Post-market: 15.630.00000.00%16:04 EDT

Volume:221.84K

Turnover:3.44M

Market Cap:584.29M

PE:55.79

High:15.63

Open:15.10

Low:15.05

Close:15.05

Loading ...

Overview Company News Filings

Bristol-Myers Adjunctive Treatment for Schizophrenia Fails to Meet Primary Endpoint

MT Newswires Live

Bristol Myers Squibb's Schizophrenia Treatment Falls Flat

Bristol Myers Squibb Co. Stock Rises Tuesday, Still Underperforms Market

Bristol-Myers Says US FDA Updates Prescribing Information for Cardiac Myosin Inhibitor Camzyos

MT Newswires Live

Bristol Myers says FDA updates Camzyos label to simplify treatment

Bristol-Myers' Camzyos Phase 3 Trial Misses Dual Primary Endpoints

MT Newswires Live

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas

Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment

FDA Approves Bristol Myers' Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients

Bristol Myers wins dismissal of proposed Pomalyst class action, Reuters reports

Elevance Health Women's Fort Myers Tip-Off comes to Scripps Sports, ION in multiyear agreement

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

Bristol-Myers Lands FDA Approval for Combination Treatment of Colorectal Cancer

MT Newswires Live

Bristol Myers assumed with Neutral from Buy at Goldman Sachs

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

Is Myers Industries, Inc. (NYSE:MYE) Potentially Undervalued?

Simply Wall St.

Bristol Myers Squibb call volume above normal and directionally bullish

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MYE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MYE\",,,,,undefined,":{"symbol":"MYE","market":"US","secType":"STK","nameCN":"Myers","latestPrice":15.63,"timestamp":1751486400000,"preClose":15.05,"halted":0,"volume":221840,"hourTrading":{"tag":"盘后","latestPrice":15.63,"preClose":15.63,"latestTime":"16:04 EDT","volume":7709,"amount":120491.67,"timestamp":1751486650060},"delay":0,"floatShares":36679840,"shares":37382291,"eps":0.28018,"marketStatus":"Closed","change":0.58,"latestTime":"07-02 16:00:00 EDT","open":15.1,"high":15.63,"low":15.05,"amount":3435674.015,"amplitude":0.038538,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.28018,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751529600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":15.05,"dividendRate":0.034549,"postHourTrading":{"tag":"盘后","latestPrice":15.63,"preClose":15.63,"latestTime":"16:04 EDT","volume":7709,"amount":120491.67,"timestamp":1751486650060},"volumeRatio":0.538023,"impliedVol":0.3908,"impliedVolPercentile":0.312},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MYE\",,,,,undefined,":{"symbol":"MYE","floatShares":36679840,"roa":"5.28%","roe":"3.69%","lyrEps":0.193882,"volumeRatio":0.538023,"shares":37382291,"dividePrice":0.54,"high":15.63,"amplitude":0.038538,"preClose":15.05,"low":15.05,"week52Low":9.06,"pbRate":"2.11","psRate":"0.70","week52High":17.39,"institutionHeld":0.9056,"latestPrice":15.63,"eps":0.28018,"divideRate":0.034549,"volume":221840,"delay":0,"ttmEps":0.28018,"open":15.1,"prevYearClose":11.04,"prevWeekClose":14.69,"prevMonthClose":14.49,"prevQuarterClose":14.49,"fiveDayClose":14.67,"twentyDayClose":13.36,"sixtyDayClose":10.38},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529687495","title":"Bristol-Myers Adjunctive Treatment for Schizophrenia Fails to Meet Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2529687495","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529687495?lang=en_us&edition=fundamental","pubTime":"2025-04-23 05:03","pubTimestamp":1745355813,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  said Tuesday that the phase 3 trial of Cobenfy, xanomeline and trospium chloride, used as an adjunctive treatment to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia did not meet its primary endpoint.The company said the treatment posted a 2-point reduction in the Positive and Negative Syndrome Scale total score, compared with placebo with an atypical antipsychotic at week 6.As per preliminary analyses, Cobenfy as an adjunctive treatment to an atypical antipsychotic showed improvements in symptoms of schizophrenia compared with placebo plus an atypical antipsychotic for certain patients, the company said.In addition, Cobenfy's safety and tolerability profile as an adjunctive treatment was consistent with previous monotherapy trials, the company added.Shares were down nearly 6% in recent after-hours activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1323610961.USD","LU2360032135.SGD","BK4588","LU1291159041.SGD","LU1670711040.USD","LU1868837136.USD","LU1868837300.USD","LU0114720955.EUR","BK4007","MYE","IE0009355771.USD","LU1571399168.USD","LU1868836757.USD","LU2125154935.USD","LU1989771016.USD","BK4532","LU0868494617.USD","LU1074936037.SGD","LU0061475181.USD","LU0225284248.USD","LU0321505868.SGD","LU1093756168.USD","LU0985481810.HKD","LU0306806265.USD","LU1670711123.USD","LU2242646821.SGD","BK4559","LU1261432733.SGD","LU1868836591.USD","IE00B2B36J28.USD","BMY","LU1670710588.SGD","BK4126","LU0306807586.USD","BK4581","LU0237698245.USD","LU0321505439.SGD","IE00BFXG1179.USD","LU1032466523.USD","LU1868836914.USD","LU0456855351.SGD","LU0882574055.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0225771236.USD","LU1585245621.USD","LU0096364046.USD","IE00BJT1NW94.SGD","BK4585"],"gpt_icon":0},{"id":"2529568735","title":"Bristol Myers Squibb's Schizophrenia Treatment Falls Flat","url":"https://stock-news.laohu8.com/highlight/detail?id=2529568735","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529568735?lang=en_us&edition=fundamental","pubTime":"2025-04-23 05:00","pubTimestamp":1745355600,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with schizophrenia.The company said Tuesday a Phase 3 trial of Cobenfy as an adjunctive treatment to atypical antipsychotics demonstrated a 2.0-point reduction in the Positive and Negative Syndrome Scale total score compared to a placebo with an atypical antipsychotic at week six.The results missed the threshold for statistical significance for the primary endpoint, the company said.Preliminary analyses suggest the treatment was associated with improved schizophrenia symptoms compared to the placebo treatment for certain patients.A post-hoc subgroup analysis showed there was a notable difference in response between subjects treated with risperidone as a background therapy and those treated with other background antipsychotics.The company said it plans to speak with regulators about potential next ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0868494617.USD","LU0985481810.HKD","LU1868837136.USD","LU0237698245.USD","BMY","IE00BFTCPJ56.SGD","BK4126","IE00BJT1NW94.SGD","LU0096364046.USD","LU1291159041.SGD","IE0009355771.USD","LU1093756325.SGD","LU1261432733.SGD","LU2125154935.USD","LU0225284248.USD","LU2360032135.SGD","LU1430594728.SGD","BK4581","LU1989771016.USD","BK4007","LU1032466523.USD","LU1571399168.USD","IE00BFXG1179.USD","LU2125154778.USD","BK4585","LU1868836914.USD","LU0061475181.USD","LU1323610961.USD","LU1670711040.USD","LU1868836757.USD","BK4588","LU0306807586.USD","LU1670710661.SGD","LU1868836591.USD","LU0306806265.USD","LU0882574055.USD","LU1074936037.SGD","LU0225771236.USD","LU1670711123.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU2242652126.USD","MYE","LU0456855351.SGD","LU0321505868.SGD","LU0114720955.EUR","LU1868837300.USD","BK4534","LU1670710588.SGD"],"gpt_icon":0},{"id":"2529557216","title":"Bristol Myers Squibb Co. Stock Rises Tuesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2529557216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529557216?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:38","pubTimestamp":1745354280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  advanced 1.80% to $49.82 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 2.51% to 5,287.76 and the Dow Jones Industrial Average  rising 2.66% to 39,186.98.The stock's rise snapped a four-day losing streak.Bristol Myers Squibb Co. closed 21.33% below its 52-week high of $63.33, which the company reached on March 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $157.75, Pfizer Inc.  rose 2.22% to $22.53, and Abbott Laboratories  rose 1.42% to $131.73.Trading volume  remained 1.2 million below its 50-day average volume of 13.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2529874698","title":"Bristol-Myers Says US FDA Updates Prescribing Information for Cardiac Myosin Inhibitor Camzyos","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874698","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874698?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:59","pubTimestamp":1745233194,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb (BMY) said late Thursday that the US Food and Drug Administration has updated prescribing information for the company's cardiac myosin inhibitor Camzyos to reduce echocardiography","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","BK4581","LU1093756325.SGD","LU1868837300.USD","IE00B2B36J28.USD","LU0061475181.USD","BK4126","LU0306807586.USD","LU0225284248.USD","LU1093756168.USD","LU0225771236.USD","LU2242652126.USD","LU1718418525.SGD","LU2125154935.USD","LU0096364046.USD","LU1032466523.USD","LU0882574055.USD","LU1291159041.SGD","BK4134","LU1074936037.SGD","IE00BFXG1179.USD","BK4007","IE00BFTCPJ56.SGD","LU1868836591.USD","III","BK4588","LU1261432733.SGD","LU1571399168.USD","BK4559","LU0456855351.SGD","LU0868494617.USD","LU1989771016.USD","LU1868836757.USD","LU1323610961.USD","LU1868836914.USD","BMY","BK4534","LU1868837136.USD","BK4532","MYE","LU2360032135.SGD","LU0985481810.HKD","LU1670711040.USD","LU0237698245.USD","LU1585245621.USD","LU0306806265.USD","IE0009355771.USD","LU2125154778.USD","LU0321505439.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2528682750","title":"Bristol Myers says FDA updates Camzyos label to simplify treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2528682750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528682750?lang=en_us&edition=fundamental","pubTime":"2025-04-18 19:00","pubTimestamp":1744974009,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb announced that the U.S. Food and Drug Administration has updated the U.S. Prescribing Information for Camzyos, simplifyi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-fda-updates-camzyos-label-to-simplify-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-fda-updates-camzyos-label-to-simplify-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2133065610.SGD","LU0096364046.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","LU0306806265.USD","BK4559","LU1585245621.USD","LU2125154935.USD","BK4588","IE00BJT1NW94.SGD","LU1074936037.SGD","LU1989771016.USD","LU1868837300.USD","LU1670710661.SGD","BK4581","LU0237698245.USD","LU2125154778.USD","IE0002141913.USD","LU0321505439.SGD","LU0321505868.SGD","BK4534","IE00BSNM7G36.USD","LU0225284248.USD","LU2242646821.SGD","BK4585","BMY","IE00B2B36J28.USD","LU1291159041.SGD","BK4532","LU1868837136.USD","BK4007","LU0868494617.USD","LU2360032135.SGD","LU1032466523.USD","LU1670711040.USD","LU1670711123.USD","LU2242652126.USD","LU1323610961.USD","LU0061475181.USD","LU1571399168.USD","LU1718418525.SGD","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU1093756168.USD","LU0985481810.HKD","MYE","LU0882574055.USD","LU0114720955.EUR","LU1430594728.SGD"],"gpt_icon":0},{"id":"2527446461","title":"Bristol-Myers' Camzyos Phase 3 Trial Misses Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2527446461","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527446461?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:48","pubTimestamp":1744663733,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  said Monday that its phase 3 Odyssey-HCM trial, which evaluated Camzyos in adults with symptomatic New York Heart Association class II-III non-obstructive hypertrophic cardiomyopathy, did not meet its dual primary endpoints.The trial failed to show a statistically significant difference from placebo in changes from baseline to week 48 in both the Kansas City Cardiomyopathy Questionnaire - Clinical Summary Score and peak oxygen consumption.No new safety signals were observed, the company added.Shares of Bristol-Myers Squibb were down 2% in after-hours trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985481810.HKD","LU1093756325.SGD","LU2242646821.SGD","LU2133065610.SGD","LU2360032135.SGD","LU1261432733.SGD","LU1585245621.USD","LU1868837136.USD","LU0321505439.SGD","LU1868836914.USD","LU0225771236.USD","BK4007","LU2125154935.USD","IE00BSNM7G36.USD","LU0061475181.USD","BK4581","BK4126","BK4532","BMY","LU0882574055.USD","LU2125154778.USD","LU1718418525.SGD","BK4534","IE00BJJMRZ35.SGD","LU0868494617.USD","LU0306807586.USD","LU1032466523.USD","LU0114720955.EUR","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","IE0002141913.USD","LU0096364046.USD","LU1868836591.USD","MYE","LU2242652126.USD","BK4585","LU0306806265.USD","LU1670710588.SGD","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0456855351.SGD","LU0237698245.USD","BK4588","LU1430594728.SGD","LU1989771016.USD","IE0009355771.USD","BK4559","LU1868836757.USD","LU1868837300.USD"],"gpt_icon":0},{"id":"2527907141","title":"Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2527907141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527907141?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:37","pubTimestamp":1744663020,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  advanced 1.24% to $51.34 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.79% to 5,405.97 and the Dow Jones Industrial Average  rising 0.78% to 40,524.79.This was the stock's second consecutive day of gains.Bristol Myers Squibb Co. closed 18.93% short of its 52-week high of $63.33, which the company achieved on March 11th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 1.73% to $154.36, Pfizer Inc.  rose 0.96% to $22.12, and Abbott Laboratories  rose 0.85% to $127.96.Trading volume  eclipsed its 50-day average volume of 13.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 14, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2527014190","title":"Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2527014190","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527014190?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:20","pubTimestamp":1744662011,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb “announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos for the treatment of adult patients with symptomatic New Yor...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-phase-3-odyssey-hcm-camzyos-trial-did-not-meet-endpoints?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-phase-3-odyssey-hcm-camzyos-trial-did-not-meet-endpoints?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836757.USD","LU1261432733.SGD","BK4559","LU0306806265.USD","LU2242646821.SGD","LU1074936037.SGD","LU1868837300.USD","LU1670710588.SGD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU0321505439.SGD","LU1430594728.SGD","LU0114720955.EUR","BK4532","IE00BJT1NW94.SGD","HCM","BK4007","IE00B2B36J28.USD","LU0306807586.USD","LU0061475181.USD","LU1571399168.USD","LU1093756325.SGD","BK4534","LU1868837136.USD","LU0985481810.HKD","LU2242652126.USD","LU1670710661.SGD","LU1291159041.SGD","BK4585","BMY","LU1718418525.SGD","LU0237698245.USD","LU1989771016.USD","IE00BSNM7G36.USD","LU1093756168.USD","BK4588","LU0225284248.USD","LU1670711040.USD","LU1868836914.USD","LU1032466523.USD","IE0009355771.USD","LU0225771236.USD","MYE","BK4581","LU2125154935.USD","LU2133065610.SGD","LU0096364046.USD","LU1323610961.USD","LU2125154778.USD","BK4531"],"gpt_icon":0},{"id":"2527814287","title":"Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527814287","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527814287?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:15","pubTimestamp":1744661700,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., April 14, 2025----Bristol Myers Squibb  today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos  for the treatment of adult patients with symptomatic New York Heart Association  class II-III non-obstructive hypertrophic cardiomyopathy  did not meet its dual primary endpoints of changes from baseline to Week 48 compared to placebo in the Kansas City Cardiomyopathy Questionnaire – Clinical Summary Score  and peak oxygen consumption . No new safety signals were observed.\"While these results are disappointing, the ODYSSEY-HCM trial meaningfully contributes to the understanding of non-obstructive HCM, a disease where there remains a significant need for new treatment options,\" said Roland Chen, MD, senior vice president, drug development, Immunology and Cardiovascular Medicines, Bristol Myers Squibb. \"These findings represent the first Phase 3 clinical trial data for a cardiac myosin inhibitor in non-obstructive HCM. Importantly, these results do not change the fav","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-provides-phase-201500074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1868836757.USD","IE00BFXG1179.USD","BK4559","LU1261432733.SGD","LU0306806265.USD","LU2242646821.SGD","LU2360032135.SGD","LU1868837300.USD","LU1670710588.SGD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU1868836591.USD","HCM","BK4532","BK4007","IE00B2B36J28.USD","LU0456855351.SGD","LU0321505868.SGD","LU0061475181.USD","LU1571399168.USD","BK4534","LU1868837136.USD","LU0882574055.USD","LU2242652126.USD","LU1670710661.SGD","IE00BJJMRZ35.SGD","LU1291159041.SGD","SD","BK4585","BMY","BK4213","BK4126","LU0237698245.USD","LU1989771016.USD","LU0868494617.USD","IE00BSNM7G36.USD","IE0002141913.USD","LU1093756168.USD","BK4588","LU1032466523.USD","IE0009355771.USD","LU0225771236.USD","LU1670711123.USD","BK4581","LU2125154935.USD","MYE","LU2133065610.SGD","LU1323610961.USD","BK4531","LU1585245621.USD"],"gpt_icon":0},{"id":"2526646177","title":"FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646177","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646177?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:33","pubTimestamp":1744403580,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb said the Food and Drug Administration approved Opdivo plus Yervoy as a first-line treatment for certain types of carcinoma.Opdivo, or nivolumab, plus Yervoy, or ipilimumab, was approved as a first-line treatment for adult patients with unresectable or metastatic hepatocellular carcinoma, the company said Friday. HCC is the most common primary liver cancer, according to the company.The company also said Phase 3 trial results showed Opdivo plus Yervoy demonstrated a statistically significant overall survival benefit compared to the investigator's choice of lenvatinib or sorafenib.The combination treatment received accelerated approval from the FDA in 2020 and has been an established second-line treatment for patients with advanced HCC who were previously treated with sorafenib.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BMY","LU1430594728.SGD","LU0061475181.USD","LU1291159041.SGD","LU0306807586.USD","BK4126","LU0882574055.USD","LU1323610961.USD","LU1571399168.USD","LU2360032135.SGD","LU1074936037.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","LU0321505868.SGD","LU0868494617.USD","BK4007","IE00BJJMRZ35.SGD","LU0456855351.SGD","IE00B2B36J28.USD","LU1093756168.USD","LU2242646821.SGD","LU1868837136.USD","LU0306806265.USD","LU1718418525.SGD","LU2125154935.USD","LU1868836591.USD","LU1670710588.SGD","LU1868836757.USD","LU1093756325.SGD","MYE","BK4532","LU0985481810.HKD","LU0225771236.USD","LU1032466523.USD","LU1670710661.SGD","LU1670711123.USD","LU1989771016.USD","IE00BFXG1179.USD","LU2125154778.USD","LU1670711040.USD","IE00BFTCPJ56.SGD","BK4534","LU0237698245.USD","LU1585245621.USD","LU1261432733.SGD","BK4581","LU1868836914.USD","LU0114720955.EUR","LU0321505439.SGD"],"gpt_icon":0},{"id":"2526643131","title":"Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526643131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526643131?lang=en_us&edition=fundamental","pubTime":"2025-04-12 03:55","pubTimestamp":1744401321,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb announced that the U.S. Food and Drug Administration approved Opdivo plus Yervoy as a first-line treatment for adult pat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-fda-approves-opdivo-plus-yervoy-as-first-line-hcc-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-says-fda-approves-opdivo-plus-yervoy-as-first-line-hcc-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4007","LU1670710588.SGD","LU1323610961.USD","BK4588","LU0225284248.USD","LU0061475181.USD","LU1718418525.SGD","LU1571399168.USD","LU1868836914.USD","HCC","LU1868836757.USD","LU2242646821.SGD","LU1093756325.SGD","BK4585","BK4559","IE00BSNM7G36.USD","LU0306806265.USD","LU2125154935.USD","LU1261432733.SGD","LU1670711123.USD","LU0985481810.HKD","LU0321505868.SGD","LU0321505439.SGD","LU1670711040.USD","LU0882574055.USD","LU1868836591.USD","LU0237698245.USD","BMY","LU0114720955.EUR","LU1868837300.USD","BK4534","LU0225771236.USD","MYE","BK4581","IE00BFTCPJ56.SGD","LU1032466523.USD","LU1670710661.SGD","LU1430594728.SGD","LU1868837136.USD","LU2133065610.SGD","LU0306807586.USD","LU2360032135.SGD","IE00BJT1NW94.SGD","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU1291159041.SGD","IE00B2B36J28.USD","BK4006","LU0868494617.USD"],"gpt_icon":0},{"id":"2526399577","title":"FDA Approves Bristol Myers' Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2526399577","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526399577?lang=en_us&edition=fundamental","pubTime":"2025-04-09 22:58","pubTimestamp":1744210733,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  on Tuesday approved Bristol Myers Squibb& Co’s  Opdivo plus Yervoy as a first-line treatment of adult and pediatric patients  with unresectable or metastatic microsatellite instability-high  or mismatch repair deficient  colorectal cancer .The approval comes ahead of over two months of the June 23, 2025, Prescription Drug User Fee Act goal date.Also Read: Europe Approves Bristol Myers’ Cell Therapy Breyanzi For Patients With Certain Type Of Blood Cancer. Opdivoas a single agent, or in combination withYervoy, was previously granted accelerated approval in MSI-H/dMMR CRC adult and pediatric patients  that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.Price Action: BMY stock is down 5.31% at $50.25 at the last check on Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-bristol-myers-opdivo-145853592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0061475181.USD","LU1868836914.USD","PFS","LU0266512127.USD","LU1868836757.USD","LU2360032135.SGD","BK4588","LU0225771236.USD","BMY","BK4213","LU1074936037.SGD","IE00BSNM7G36.USD","BK4211","LU1670710661.SGD","LU0306806265.USD","LU2242646821.SGD","LU0456855351.SGD","LU0882574055.USD","LU1032466523.USD","LU0114720955.EUR","LU1868836591.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU0321505868.SGD","IE00B2B36J28.USD","BK4195","LU1093756168.USD","LU0306807586.USD","LU1571399168.USD","LU1989771016.USD","BK4126","LU1291159041.SGD","LU1323610961.USD","BK4559","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU1718418525.SGD","BK4585","LU1868837136.USD","BK4534","ORR","LU0321505439.SGD","LU2125154778.USD","LU2133065610.SGD","MYE","BK4532","LU0985481810.HKD","LU1670711123.USD","LU1670711040.USD","CRC"],"gpt_icon":0},{"id":"2526367652","title":"Bristol Myers wins dismissal of proposed Pomalyst class action, Reuters reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2526367652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526367652?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:51","pubTimestamp":1744206701,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent lawsui...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-wins-dismissal-of-proposed-pomalyst-class-action-reuters-reports?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-wins-dismissal-of-proposed-pomalyst-class-action-reuters-reports?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0882574055.USD","LU0061475181.USD","LU0321505439.SGD","LU1323610961.USD","LU1868836757.USD","LU1670711040.USD","LU1032466523.USD","LU1291159041.SGD","LU2242652126.USD","LU2133065610.SGD","BK4532","LU0985481810.HKD","LU1989771016.USD","LU1571399168.USD","LU1074936037.SGD","LU1093756168.USD","LU0321505868.SGD","IE0009355771.USD","LU2125154778.USD","LU0237698245.USD","MYE","BMY","LU2242646821.SGD","LU2125154935.USD","LU0114720955.EUR","LU1868837300.USD","BK4585","IE0002141913.USD","BK4588","LU0225771236.USD","LU1868836591.USD","LU1261432733.SGD","LU1430594728.SGD","LU1585245621.USD","LU0096364046.USD","LU0306806265.USD","IE00BSNM7G36.USD","LU0306807586.USD","IE00BFXG1179.USD","BK4559","LU2360032135.SGD","LU0225284248.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4007","LU0456855351.SGD","LU1670710661.SGD","LU1868836914.USD","BK4534","LU1718418525.SGD"],"gpt_icon":0},{"id":"2526336468","title":"Elevance Health Women's Fort Myers Tip-Off comes to Scripps Sports, ION in multiyear agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2526336468","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526336468?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:00","pubTimestamp":1744203600,"startTime":"0","endTime":"0","summary":"First national women's college basketball rights deal for Scripps Sports. ATLANTA, April 9, 2025 /PRNewswire/ -- ION will be the exclusive television home of the popularElevance HealthWomen's Fort Myers Tip-Off, a premier early season college basketball tournament, for the next five years as part of a new multiyear agreement between Scripps Sports and award-winning agency Intersport, which manages the tournament.The addition of the Elevance Health Women's Fort Myers Tip-Off to Scripps Sports comes as ION has seen significant momentum with its sports programming centered around the WNBA and the NWSL. The WNBA on ION reached more than 23.3 million total unique viewers last season, including 9.4 million viewers unique to ION, with seven WNBA telecasts exceeding 1 million viewers.Broadcasts of last year's inaugural season of the NWSL on ION reached more than 20.5 million total unique viewers, including 13.5 viewers unique to ION.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/elevance-health-womens-fort-myers-130000964.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elevance-health-womens-fort-myers-130000964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0068578508.USD","BK4125","LU0878866978.SGD","LU1670627923.USD","MYE","SGXZ23171101.USD","BK4006","LU0266013472.USD","SG9999011175.SGD","LU0640476718.USD","LU0114720955.EUR","LU0048573561.USD","LU0122379950.USD","LU0320765489.SGD","LU0557290698.USD","LU0957791311.USD","LU0985489474.SGD","LU1720051017.SGD","LU0433182093.SGD","LU1548497426.USD","LU0058720904.USD","LU2362540622.SGD","SSP","LU0234570918.USD","LU0187121727.USD","LU2592432038.USD","LU0006306889.USD","LU0225283273.USD","LU2237957811.SGD","LU1489326972.SGD","ION","LU0345770993.USD","LU1815333072.USD","LU1720051108.HKD","LU2357305700.SGD","LU2362541273.HKD","X","BK4520","LU0211331839.USD","LU1057294990.SGD","LU0742534661.SGD","ELV","BK4588","BK4516","LU1506573853.SGD","LU1983299246.USD","LU2505996509.AUD","LU1023059063.AUD","LU0251142724.SGD","LU0314106906.USD"],"gpt_icon":0},{"id":"2526233618","title":"Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2526233618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526233618?lang=en_us&edition=fundamental","pubTime":"2025-04-09 04:37","pubTimestamp":1744144620,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slid 3.84% to $53.07 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 1.57% to 4,982.77 and Dow Jones Industrial Average  falling 0.84% to 37,645.59.This was the stock's fourth consecutive day of losses.Bristol Myers Squibb Co. closed 16.20% below its 52-week high of $63.33, which the company achieved on March 11th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 0.41% to $150.00, Pfizer Inc.  fell 3.49% to $21.84, and Abbott Laboratories  fell 0.73% to $123.95.Trading volume  eclipsed its 50-day average volume of 12.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2526849249","title":"Bristol-Myers Lands FDA Approval for Combination Treatment of Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2526849249","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526849249?lang=en_us&edition=fundamental","pubTime":"2025-04-09 01:57","pubTimestamp":1744135039,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  received approval from the US Food and Drug Administration for nivolumab with ipilimumab to treat a colorectal cancer type in patients 12 years or older, the regulator said Tuesday.The combination was tested in a randomized, three-arm, open-label trial in immunotherapy-naive patients with unresectable or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.The FDA also converted the accelerated approval to regular approval for single agent nivolumab for patients 12 years or older with the disease, that has progressed following fluoropyrimidine, oxaliplatin, and irinotecan.Price: 53.37, Change: -1.82, Percent Change: -3.30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4126","IE00B2B36J28.USD","LU1093756325.SGD","LU1093756168.USD","LU1571399168.USD","LU0321505868.SGD","BK4588","LU2125154935.USD","BK4534","LU0985481810.HKD","LU1989771016.USD","LU1868836591.USD","BMY","LU1670711123.USD","LU1074936037.SGD","LU0096364046.USD","LU1585245621.USD","LU0237698245.USD","LU0061475181.USD","LU1261432733.SGD","LU1718418525.SGD","LU1868836914.USD","LU1868837300.USD","IE00BSNM7G36.USD","BK4559","LU0868494617.USD","IE0009355771.USD","LU1670710661.SGD","LU1032466523.USD","LU0306807586.USD","LU2360032135.SGD","IE0002141913.USD","BK4585","LU0306806265.USD","LU0321505439.SGD","LU0114720955.EUR","LU2125154778.USD","BK4581","LU2133065610.SGD","LU2242646821.SGD","LU0225771236.USD","LU2242652126.USD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU1868837136.USD","MYE","LU1323610961.USD","LU1868836757.USD","LU1291159041.SGD","LU1670710588.SGD"],"gpt_icon":0},{"id":"2525130857","title":"Bristol Myers assumed with Neutral from Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2525130857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525130857?lang=en_us&edition=fundamental","pubTime":"2025-04-08 16:45","pubTimestamp":1744101930,"startTime":"0","endTime":"0","summary":"Goldman Sachs downgraded Bristol Myers (BMY) to Neutral from Buy with a price target of $55, down from $67, after assuming coverage of the name. Wh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-assumed-with-neutral-from-buy-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-assumed-with-neutral-from-buy-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYE"],"gpt_icon":0},{"id":"2525301797","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2525301797","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525301797?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:36","pubTimestamp":1743798960,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  shed 3.32% to $55.30 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 5.97% to 5,074.08 and Dow Jones Industrial Average  falling 5.50% to 38,314.86.This was the stock's second consecutive day of losses.Bristol Myers Squibb Co. closed 12.68% below its 52-week high of $63.33, which the company reached on March 11th.Despite its losses, the stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 4.12% to $153.24, Pfizer Inc.  fell 5.43% to $22.97, and Abbott Laboratories  fell 5.46% to $124.44.Trading volume  eclipsed its 50-day average volume of 12.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 4, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYE","BMY"],"gpt_icon":0},{"id":"2524297070","title":"Is Myers Industries, Inc. (NYSE:MYE) Potentially Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524297070","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524297070?lang=en_us&edition=fundamental","pubTime":"2025-04-04 02:46","pubTimestamp":1743705993,"startTime":"0","endTime":"0","summary":"Myers Industries, Inc. , is not the largest company out there, but it received a lot of attention from a substantial price increase on the NYSE over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy?Today we will analyse the most recent data on Myers Industries’s outlook and valuation to see if the opportunity still exists.Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/myers-industries-inc-nyse-mye-184633274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MYE","BK4126","NYSE"],"gpt_icon":0},{"id":"2524975322","title":"Bristol Myers Squibb call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2524975322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524975322?lang=en_us&edition=fundamental","pubTime":"2025-04-04 02:45","pubTimestamp":1743705913,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Bristol Myers (BMY) Squibb with 37,216 calls trading, 3x expected, and implied vol increasing almost 3 points to 39...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-squibb-call-volume-above-normal-and-directionally-bullish-10?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-squibb-call-volume-above-normal-and-directionally-bullish-10?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1261432733.SGD","LU1291159041.SGD","LU0061475181.USD","LU1868836914.USD","BMY","LU1430594728.SGD","LU0096364046.USD","MYE","LU0237698245.USD","LU2242652126.USD","BK4581","LU1093756325.SGD","IE00BFXG1179.USD","LU0225771236.USD","LU2125154778.USD","LU0306807586.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1670710588.SGD","LU1989771016.USD","BK4532","IE00BSNM7G36.USD","LU1670711123.USD","BK4007","LU0321505439.SGD","LU2125154935.USD","LU1868837136.USD","LU2360032135.SGD","BK4559","BK4585","LU0321505868.SGD","BK4588","BK4126","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU1868836591.USD","LU1032466523.USD","LU0456855351.SGD","LU1074936037.SGD","LU1585245621.USD","LU1670710661.SGD","LU2133065610.SGD","LU2242646821.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU0985481810.HKD","LU0306806265.USD","LU0868494617.USD","LU1718418525.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":198,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYE\",params:#limit:5,,,undefined,":[{"date":"2025-06-18","symbol":"MYE","amount":0.135,"announcedDate":"2025-06-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-18","defaultRemindTime":1750253400000,"name":"Myers Industries Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-03","payableDate":"2025-06-18","currency":"USD","dateTimestamp":1750219200000,"payDate":"2025-07-03"},{"date":"2025-05-01","symbol":"MYE","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1746086400000,"name":null,"time":"Pre-Market","dateTimestamp":1746072000000,"actualEps":null},{"date":"2025-03-14","symbol":"MYE","amount":0.135,"announcedDate":"2025-03-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-14","defaultRemindTime":1741959000000,"name":"Myers Industries Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-04","payableDate":"2025-03-14","currency":"USD","dateTimestamp":1741924800000,"payDate":"2025-04-04"},{"market":"US","date":"2025-03-06","symbol":"MYE","fiscalQuarterEnding":"2024/12","expectedEps":0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"pre","actualEps":0.19},{"date":"2024-12-03","symbol":"MYE","amount":0.135,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-03","defaultRemindTime":1733236200000,"name":"Myers Industries Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-03","payableDate":"2024-12-03","currency":"USD","dateTimestamp":1733202000000,"payDate":"2025-01-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYE\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-02","recordDate":"2015-09-04","paymentDate":"2015-10-05","value":0.135,"currency":"USD"},{"executeDate":"2015-11-24","recordDate":"2015-11-27","paymentDate":"2016-01-04","value":0.135,"currency":"USD"},{"executeDate":"2016-03-11","recordDate":"2016-03-15","paymentDate":"2016-04-04","value":0.135,"currency":"USD"},{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-07-05","value":0.135,"currency":"USD"},{"executeDate":"2016-08-31","recordDate":"2016-09-02","paymentDate":"2016-10-03","value":0.135,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MYE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1749787200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MYE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MYE","date":"2025-07-01","current":51.572826,"percent":0.968675,"low":11.194867,"twenty":13.304671,"median":16.429557,"eighty":25.69559,"high":67.952097,"avg":20.404954,"sd":10.132863,"marketCap":541669396},"quantilePoints":[{"date":"2020-07-02","current":14.927217,"twenty":-102.769389,"median":28.379689,"eighty":105.89939,"marketCap":511839350},{"date":"2020-07-10","current":14.645572,"twenty":-102.769389,"median":28.311814,"eighty":105.89939,"marketCap":502182003},{"date":"2020-07-17","current":15.365333,"twenty":-102.769389,"median":28.254397,"eighty":105.89939,"marketCap":526861888},{"date":"2020-07-24","current":15.188,"twenty":-102.769389,"median":28.236367,"eighty":105.89939,"marketCap":520781337},{"date":"2020-07-31","current":14.952987,"twenty":-102.769389,"median":28.236367,"eighty":105.89939,"marketCap":539070139},{"date":"2020-08-07","current":16.134531,"twenty":-102.769389,"median":28.20152,"eighty":105.89939,"marketCap":581665987},{"date":"2020-08-14","current":16.452257,"twenty":-102.769389,"median":28.182185,"eighty":105.89939,"marketCap":593120333},{"date":"2020-08-21","current":15.6778,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":565200365},{"date":"2020-08-28","current":15.48915,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":558399348},{"date":"2020-09-04","current":15.012561,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":541217829},{"date":"2020-09-11","current":14.36718,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":517951190},{"date":"2020-09-18","current":13.811159,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":497906085},{"date":"2020-09-25","current":12.937412,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":466406634},{"date":"2020-10-02","current":13.553006,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":488599429},{"date":"2020-10-09","current":14.555829,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":524752207},{"date":"2020-10-16","current":14.45654,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":521172724},{"date":"2020-10-23","current":14.64519,"twenty":-102.769389,"median":28.13764,"eighty":105.89939,"marketCap":527973742},{"date":"2020-10-30","current":13.000269,"twenty":-102.769389,"median":28.125162,"eighty":105.89939,"marketCap":513731632},{"date":"2020-11-06","current":13.716462,"twenty":-102.769389,"median":28.082741,"eighty":105.89939,"marketCap":542033445},{"date":"2020-11-13","current":14.768088,"twenty":-102.769389,"median":27.997899,"eighty":105.89939,"marketCap":583590536},{"date":"2020-11-20","current":16.118883,"twenty":-102.769389,"median":27.913057,"eighty":105.89939,"marketCap":636969904},{"date":"2020-11-27","current":15.919437,"twenty":-102.769389,"median":27.828215,"eighty":105.89939,"marketCap":629088387},{"date":"2020-12-04","current":16.245803,"twenty":-102.769389,"median":27.531267,"eighty":105.89939,"marketCap":641985415},{"date":"2020-12-11","current":17.107049,"twenty":-102.769389,"median":27.107057,"eighty":105.89939,"marketCap":676019240},{"date":"2020-12-18","current":17.705387,"twenty":-102.769389,"median":26.496194,"eighty":105.89939,"marketCap":699663792},{"date":"2020-12-24","current":18.367186,"twenty":-102.769389,"median":23.976382,"eighty":105.89939,"marketCap":725816100},{"date":"2020-12-31","current":18.838605,"twenty":-102.769389,"median":21.604242,"eighty":105.89939,"marketCap":744445141},{"date":"2021-01-08","current":19.627324,"twenty":-102.769389,"median":19.81301,"eighty":105.89939,"marketCap":775612960},{"date":"2021-01-15","current":20.25286,"twenty":-102.769389,"median":19.81301,"eighty":105.89939,"marketCap":800332264},{"date":"2021-01-22","current":20.171268,"twenty":-102.769389,"median":19.81301,"eighty":105.89939,"marketCap":797108007},{"date":"2021-01-29","current":18.176806,"twenty":-102.769389,"median":19.331452,"eighty":105.89939,"marketCap":718292833},{"date":"2021-02-05","current":19.418812,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":767373192},{"date":"2021-02-12","current":20.098742,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":794242001},{"date":"2021-02-19","current":19.835836,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":783852728},{"date":"2021-02-26","current":20.071545,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":793167249},{"date":"2021-03-05","current":20.144071,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":796033255},{"date":"2021-03-12","current":19.184819,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":705406612},{"date":"2021-03-19","current":20.213102,"twenty":-102.769389,"median":18.84767,"eighty":105.89939,"marketCap":743215543},{"date":"2021-03-26","current":19.140481,"twenty":-102.751708,"median":18.838605,"eighty":105.704483,"marketCap":703776347},{"date":"2021-04-01","current":20.180405,"twenty":-102.751708,"median":18.838605,"eighty":105.704483,"marketCap":742013299},{"date":"2021-04-09","current":20.200026,"twenty":-102.769389,"median":18.830174,"eighty":105.89939,"marketCap":742734751},{"date":"2021-04-16","current":20.92601,"twenty":-102.769389,"median":18.830174,"eighty":105.89939,"marketCap":769428472},{"date":"2021-04-23","current":21.367487,"twenty":-102.769389,"median":18.830174,"eighty":105.89939,"marketCap":785661140},{"date":"2021-04-30","current":22.132714,"twenty":-102.769389,"median":18.830174,"eighty":105.89939,"marketCap":813797765},{"date":"2021-05-07","current":28.754665,"twenty":-102.769389,"median":19.116463,"eighty":105.89939,"marketCap":786382592},{"date":"2021-05-14","current":28.580916,"twenty":-102.680982,"median":19.268462,"eighty":105.89939,"marketCap":781630882},{"date":"2021-05-21","current":28.343401,"twenty":-102.522475,"median":19.489,"eighty":105.89939,"marketCap":775135335},{"date":"2021-05-28","current":29.06914,"twenty":-102.326198,"median":19.625149,"eighty":105.89939,"marketCap":794982841},{"date":"2021-06-04","current":28.633697,"twenty":-101.927017,"median":19.797836,"eighty":105.89939,"marketCap":783074337},{"date":"2021-06-11","current":28.185058,"twenty":-101.737364,"median":19.903314,"eighty":105.89939,"marketCap":770804970},{"date":"2021-06-18","current":27.235,"twenty":-101.084645,"median":20.035282,"eighty":105.89939,"marketCap":744822780},{"date":"2021-06-25","current":28.053106,"twenty":-99.663066,"median":20.085144,"eighty":105.89939,"marketCap":767196332},{"date":"2021-07-02","current":27.617662,"twenty":-98.333879,"median":20.162202,"eighty":105.89939,"marketCap":755287828},{"date":"2021-07-09","current":27.815591,"twenty":-74.66105,"median":20.219383,"eighty":105.89939,"marketCap":760700785},{"date":"2021-07-16","current":27.142633,"twenty":-73.426983,"median":20.28497,"eighty":105.89939,"marketCap":742296733},{"date":"2021-07-23","current":27.907958,"twenty":-72.347175,"median":20.397447,"eighty":105.89939,"marketCap":763226831},{"date":"2021-07-30","current":27.947544,"twenty":-71.267366,"median":20.641503,"eighty":105.89939,"marketCap":764309422},{"date":"2021-08-06","current":25.98267,"twenty":-70.341816,"median":20.831231,"eighty":104.600011,"marketCap":780909155},{"date":"2021-08-13","current":26.454873,"twenty":-70.341816,"median":20.831231,"eighty":103.300632,"marketCap":795101223},{"date":"2021-08-20","current":27.357565,"twenty":-70.341816,"median":20.831231,"eighty":101.285368,"marketCap":822231610},{"date":"2021-08-27","current":27.586247,"twenty":-70.341816,"median":20.831231,"eighty":97.712492,"marketCap":829104642},{"date":"2021-09-03","current":27.140919,"twenty":-70.249261,"median":20.847525,"eighty":97.115943,"marketCap":815720317},{"date":"2021-09-10","current":25.275357,"twenty":-70.249261,"median":20.847525,"eighty":96.741838,"marketCap":759650850},{"date":"2021-09-17","current":23.710692,"twenty":-70.249261,"median":20.847525,"eighty":96.349306,"marketCap":712624845},{"date":"2021-09-24","current":24.023625,"twenty":-70.249261,"median":20.847525,"eighty":95.603339,"marketCap":722030046},{"date":"2021-10-01","current":24.204163,"twenty":-70.249261,"median":20.847525,"eighty":94.80053,"marketCap":727456123},{"date":"2021-10-08","current":24.493024,"twenty":-70.156706,"median":20.849362,"eighty":94.76077,"marketCap":736137847},{"date":"2021-10-15","current":24.50506,"twenty":-70.156706,"median":20.849362,"eighty":94.011499,"marketCap":736499586},{"date":"2021-10-22","current":24.517096,"twenty":-70.156706,"median":20.849362,"eighty":93.829876,"marketCap":736861324},{"date":"2021-10-29","current":24.76985,"twenty":-70.156706,"median":20.849362,"eighty":93.506325,"marketCap":744457833},{"date":"2021-11-05","current":25.579841,"twenty":-70.156706,"median":20.849362,"eighty":93.204001,"marketCap":748798695},{"date":"2021-11-12","current":26.628808,"twenty":-70.156706,"median":20.849362,"eighty":93.182774,"marketCap":779505084},{"date":"2021-11-19","current":25.366075,"twenty":-70.156706,"median":20.849362,"eighty":92.535671,"marketCap":742541105},{"date":"2021-11-26","current":25.341315,"twenty":-70.156706,"median":20.849362,"eighty":92.529518,"marketCap":741816321},{"date":"2021-12-03","current":23.954785,"twenty":-70.156706,"median":20.849362,"eighty":92.336658,"marketCap":701228423},{"date":"2021-12-10","current":24.784227,"twenty":-70.156706,"median":20.849362,"eighty":91.888568,"marketCap":725508683},{"date":"2021-12-17","current":23.694811,"twenty":-70.156706,"median":20.849362,"eighty":91.108039,"marketCap":693618192},{"date":"2021-12-23","current":24.375696,"twenty":-70.156706,"median":20.849362,"eighty":90.594363,"marketCap":713549749},{"date":"2021-12-31","current":24.771847,"twenty":-70.156706,"median":20.849362,"eighty":90.594363,"marketCap":725146291},{"date":"2022-01-07","current":24.115722,"twenty":-70.064151,"median":20.851199,"eighty":90.257041,"marketCap":705939518},{"date":"2022-01-14","current":23.806228,"twenty":-70.064151,"median":20.851199,"eighty":89.932841,"marketCap":696879719},{"date":"2022-01-21","current":22.531116,"twenty":-70.064151,"median":20.851199,"eighty":89.932841,"marketCap":659553349},{"date":"2022-01-28","current":21.899749,"twenty":-69.971596,"median":20.888604,"eighty":89.359845,"marketCap":641071359},{"date":"2022-02-04","current":20.723675,"twenty":-69.971596,"median":20.849362,"eighty":89.084872,"marketCap":606644124},{"date":"2022-02-11","current":20.537979,"twenty":-69.971596,"median":20.711295,"eighty":87.796956,"marketCap":601208245},{"date":"2022-02-18","current":21.40456,"twenty":-69.971596,"median":20.711295,"eighty":87.091759,"marketCap":626575681},{"date":"2022-02-25","current":20.785573,"twenty":-69.971596,"median":20.626061,"eighty":86.868909,"marketCap":608456084},{"date":"2022-03-04","current":20.550358,"twenty":-69.971596,"median":20.513219,"eighty":85.945815,"marketCap":601570637},{"date":"2022-03-11","current":19.352495,"twenty":-69.971596,"median":20.403924,"eighty":84.888021,"marketCap":649043982},{"date":"2022-03-18","current":21.58984,"twenty":-69.971596,"median":20.389134,"eighty":62.530443,"marketCap":724080057},{"date":"2022-03-25","current":22.574146,"twenty":-69.971596,"median":20.389134,"eighty":61.476189,"marketCap":757091723},{"date":"2022-04-01","current":23.039258,"twenty":-69.971596,"median":20.389134,"eighty":60.619608,"marketCap":772690642},{"date":"2022-04-08","current":22.401082,"twenty":-69.971596,"median":20.389134,"eighty":60.125427,"marketCap":751287474},{"date":"2022-04-14","current":22.617413,"twenty":-69.971596,"median":20.389134,"eighty":59.960699,"marketCap":758542785},{"date":"2022-04-22","current":23.169057,"twenty":-69.971596,"median":20.389134,"eighty":59.631245,"marketCap":777043829},{"date":"2022-04-29","current":23.720701,"twenty":-69.971596,"median":20.389134,"eighty":59.170009,"marketCap":795544873},{"date":"2022-05-06","current":19.591172,"twenty":-69.971596,"median":20.372221,"eighty":58.840554,"marketCap":853587362},{"date":"2022-05-13","current":19.627527,"twenty":-69.971596,"median":20.302002,"eighty":58.840554,"marketCap":855171331},{"date":"2022-05-20","current":18.885134,"twenty":-69.971596,"median":20.248327,"eighty":58.840554,"marketCap":822825284},{"date":"2022-05-27","current":20.219772,"twenty":-69.971596,"median":20.206564,"eighty":58.840554,"marketCap":880975481},{"date":"2022-06-03","current":20.920458,"twenty":-69.971596,"median":20.190216,"eighty":58.840554,"marketCap":911504334},{"date":"2022-06-10","current":19.894454,"twenty":-69.971596,"median":20.175837,"eighty":57.259173,"marketCap":866801371},{"date":"2022-06-17","current":18.35962,"twenty":-69.971596,"median":20.130472,"eighty":29.413065,"marketCap":799928644},{"date":"2022-06-24","current":18.876792,"twenty":-70.064151,"median":20.044348,"eighty":29.04744,"marketCap":822461845},{"date":"2022-07-01","current":18.935183,"twenty":-70.064151,"median":20.026216,"eighty":28.863288,"marketCap":825005917},{"date":"2022-07-08","current":18.518108,"twenty":-70.064151,"median":19.894454,"eighty":28.812383,"marketCap":806833980},{"date":"2022-07-15","current":18.367962,"twenty":-70.064151,"median":19.835836,"eighty":28.727541,"marketCap":800292083},{"date":"2022-07-22","current":18.985232,"twenty":-70.064151,"median":19.752295,"eighty":28.633697,"marketCap":827186549},{"date":"2022-07-29","current":20.294846,"twenty":-70.064151,"median":19.672653,"eighty":28.489983,"marketCap":884246430},{"date":"2022-08-05","current":16.251937,"twenty":-70.064151,"median":19.627324,"eighty":28.422109,"marketCap":785391095},{"date":"2022-08-12","current":16.420853,"twenty":-70.064151,"median":19.577478,"eighty":28.375917,"marketCap":793554146},{"date":"2022-08-19","current":16.534048,"twenty":-70.064151,"median":19.460697,"eighty":28.318326,"marketCap":799024418},{"date":"2022-08-26","current":15.424735,"twenty":-70.064151,"median":19.385746,"eighty":28.242244,"marketCap":745415751},{"date":"2022-09-02","current":14.119217,"twenty":-70.064151,"median":19.263164,"eighty":28.191643,"marketCap":682325279},{"date":"2022-09-09","current":14.141856,"twenty":-70.064151,"median":19.210452,"eighty":28.176938,"marketCap":683419333},{"date":"2022-09-16","current":13.289119,"twenty":-70.064151,"median":19.140481,"eighty":28.11764,"marketCap":642209950},{"date":"2022-09-23","current":12.685411,"twenty":-70.064151,"median":19.012943,"eighty":28.06496,"marketCap":613035165},{"date":"2022-09-30","current":12.428835,"twenty":-70.064151,"median":18.935183,"eighty":27.998869,"marketCap":600635882},{"date":"2022-10-07","current":12.300547,"twenty":-70.064151,"median":18.856736,"eighty":27.973934,"marketCap":594436240},{"date":"2022-10-14","current":12.87407,"twenty":-70.064151,"median":18.745821,"eighty":27.946994,"marketCap":622152285},{"date":"2022-10-21","current":13.296665,"twenty":-70.064151,"median":18.634889,"eighty":27.909998,"marketCap":642574635},{"date":"2022-10-28","current":13.460325,"twenty":-70.064151,"median":18.518108,"eighty":27.857967,"marketCap":728122810},{"date":"2022-11-04","current":14.182257,"twenty":-70.064151,"median":18.367962,"eighty":27.802803,"marketCap":767175011},{"date":"2022-11-11","current":14.438644,"twenty":-70.064151,"median":18.176806,"eighty":27.715307,"marketCap":781044017},{"date":"2022-11-18","current":15.099853,"twenty":-70.064151,"median":18.076009,"eighty":27.710029,"marketCap":816811453},{"date":"2022-11-25","current":15.17407,"twenty":-70.064151,"median":17.967803,"eighty":27.632378,"marketCap":820826166},{"date":"2022-12-02","current":15.713833,"twenty":-70.064151,"median":17.382951,"eighty":27.503734,"marketCap":850024073},{"date":"2022-12-09","current":15.65311,"twenty":-70.064151,"median":17.162728,"eighty":27.420151,"marketCap":846739308},{"date":"2022-12-16","current":15.167323,"twenty":-70.064151,"median":16.853582,"eighty":27.357565,"marketCap":820461192},{"date":"2022-12-23","current":15.599133,"twenty":-70.064151,"median":16.630978,"eighty":27.207437,"marketCap":843819518},{"date":"2022-12-30","current":14.998648,"twenty":-70.064151,"median":16.579326,"eighty":27.126113,"marketCap":811336846},{"date":"2023-01-06","current":15.329252,"twenty":-70.064151,"median":16.452257,"eighty":26.959431,"marketCap":829220564},{"date":"2023-01-13","current":16.698899,"twenty":-70.064151,"median":16.413307,"eighty":26.593434,"marketCap":903310254},{"date":"2023-01-20","current":16.111908,"twenty":-70.064151,"median":16.352936,"eighty":26.409227,"marketCap":871557529},{"date":"2023-01-27","current":15.997208,"twenty":-70.064151,"median":16.236896,"eighty":26.207374,"marketCap":865352974},{"date":"2023-02-03","current":16.449259,"twenty":-70.064151,"median":16.226607,"eighty":25.93733,"marketCap":889806221},{"date":"2023-02-10","current":15.862267,"twenty":-70.064151,"median":16.171824,"eighty":25.643827,"marketCap":858053497},{"date":"2023-02-17","current":16.644923,"twenty":-70.064151,"median":16.134531,"eighty":25.531963,"marketCap":900390463},{"date":"2023-02-24","current":16.611188,"twenty":-70.064151,"median":16.134531,"eighty":25.405029,"marketCap":898565594},{"date":"2023-03-03","current":12.86889,"twenty":-70.064151,"median":16.118655,"eighty":25.351219,"marketCap":775569410},{"date":"2023-03-10","current":12.449174,"twenty":-70.064151,"median":16.116388,"eighty":25.30174,"marketCap":750274360},{"date":"2023-03-17","current":11.969893,"twenty":-70.064151,"median":16.116388,"eighty":25.30174,"marketCap":721389528},{"date":"2023-03-24","current":12.467374,"twenty":-70.064151,"median":16.116388,"eighty":25.30174,"marketCap":751371252},{"date":"2023-03-31","current":13.001257,"twenty":-69.971596,"median":16.114148,"eighty":25.288549,"marketCap":783546761},{"date":"2023-04-06","current":12.455241,"twenty":-68.891787,"median":16.114148,"eighty":25.288549,"marketCap":750639991},{"date":"2023-04-14","current":12.400639,"twenty":-25.987154,"median":16.116388,"eighty":25.30174,"marketCap":747349314},{"date":"2023-04-21","current":12.327837,"twenty":-24.776251,"median":16.116388,"eighty":25.30174,"marketCap":742961744},{"date":"2023-04-28","current":11.460277,"twenty":-24.466142,"median":16.116388,"eighty":25.30174,"marketCap":690676543},{"date":"2023-05-05","current":12.040322,"twenty":-24.377539,"median":16.116388,"eighty":25.30174,"marketCap":673126265},{"date":"2023-05-12","current":12.4869,"twenty":-24.271216,"median":16.116388,"eighty":25.30174,"marketCap":698092642},{"date":"2023-05-19","current":12.907512,"twenty":-24.144218,"median":16.116388,"eighty":25.30174,"marketCap":721607341},{"date":"2023-05-26","current":12.736638,"twenty":-24.002454,"median":16.116388,"eighty":25.30174,"marketCap":712054494},{"date":"2023-06-01","current":12.289739,"twenty":-23.949293,"median":16.116388,"eighty":25.30174,"marketCap":687070126},{"date":"2023-06-09","current":13.492424,"twenty":-23.789808,"median":16.118655,"eighty":25.328123,"marketCap":754307470},{"date":"2023-06-16","current":13.098101,"twenty":-23.701205,"median":16.118655,"eighty":25.328123,"marketCap":732262439},{"date":"2023-06-23","current":12.881223,"twenty":-23.538767,"median":16.118655,"eighty":25.341315,"marketCap":720137672},{"date":"2023-06-29","current":12.638057,"twenty":-23.314307,"median":16.118655,"eighty":25.346267,"marketCap":706543237},{"date":"2023-07-07","current":12.703778,"twenty":-22.762018,"median":16.118769,"eighty":25.351219,"marketCap":710217408},{"date":"2023-07-14","current":12.736638,"twenty":-22.319004,"median":16.118769,"eighty":25.351219,"marketCap":712054494},{"date":"2023-07-21","current":13.019236,"twenty":-21.943919,"median":16.118769,"eighty":25.351219,"marketCap":727853433},{"date":"2023-07-28","current":13.052097,"twenty":11.078643,"median":16.118769,"eighty":25.351219,"marketCap":729690519},{"date":"2023-08-04","current":13.607775,"twenty":11.078643,"median":16.104325,"eighty":25.09416,"marketCap":689642046},{"date":"2023-08-11","current":13.865316,"twenty":11.078643,"median":16.024882,"eighty":24.826318,"marketCap":702694194},{"date":"2023-08-18","current":13.691,"twenty":11.078643,"median":15.967904,"eighty":24.770649,"marketCap":693859904},{"date":"2023-08-25","current":13.335107,"twenty":11.078643,"median":15.943696,"eighty":24.702409,"marketCap":675823227},{"date":"2023-09-01","current":13.661948,"twenty":11.078643,"median":15.898654,"eighty":24.580826,"marketCap":692387522},{"date":"2023-09-08","current":13.001003,"twenty":11.078643,"median":15.879444,"eighty":24.509874,"marketCap":658890837},{"date":"2023-09-15","current":13.051845,"twenty":11.078643,"median":15.811664,"eighty":24.450138,"marketCap":661467505},{"date":"2023-09-22","current":13.080898,"twenty":11.078643,"median":15.744194,"eighty":24.373878,"marketCap":662939887},{"date":"2023-09-29","current":13.218897,"twenty":11.078643,"median":15.717206,"eighty":24.279088,"marketCap":669933700},{"date":"2023-10-06","current":12.659636,"twenty":11.078643,"median":15.682322,"eighty":24.18972,"marketCap":641590351},{"date":"2023-10-13","current":12.76132,"twenty":11.078643,"median":15.633286,"eighty":24.125626,"marketCap":646743688},{"date":"2023-10-20","current":12.325532,"twenty":11.078643,"median":15.567659,"eighty":23.958249,"marketCap":624657961},{"date":"2023-10-27","current":12.165743,"twenty":10.642694,"median":15.48915,"eighty":23.89123,"marketCap":616559862},{"date":"2023-11-03","current":12.882654,"twenty":10.642694,"median":15.444987,"eighty":23.720701,"marketCap":640989308},{"date":"2023-11-10","current":12.342174,"twenty":11.460277,"median":15.438953,"eighty":23.71957,"marketCap":614097228},{"date":"2023-11-17","current":12.941884,"twenty":11.912566,"median":15.438953,"eighty":23.71957,"marketCap":643936385},{"date":"2023-11-24","current":12.986307,"twenty":11.984165,"median":15.438953,"eighty":23.71957,"marketCap":646146693},{"date":"2023-12-01","current":13.045538,"twenty":12.115497,"median":15.438953,"eighty":23.71957,"marketCap":649093770},{"date":"2023-12-08","current":13.526786,"twenty":12.225913,"median":15.434629,"eighty":23.717794,"marketCap":673038773},{"date":"2023-12-15","current":14.533706,"twenty":12.27469,"median":15.438953,"eighty":23.71957,"marketCap":723139087},{"date":"2023-12-22","current":14.748417,"twenty":12.315703,"median":15.438953,"eighty":23.71957,"marketCap":733822242},{"date":"2023-12-29","current":14.600341,"twenty":12.327837,"median":15.44197,"eighty":23.719796,"marketCap":726454549},{"date":"2024-01-05","current":14.111688,"twenty":12.359936,"median":15.444987,"eighty":23.720022,"marketCap":702141161},{"date":"2024-01-12","current":13.652651,"twenty":12.419237,"median":15.444987,"eighty":23.720022,"marketCap":679301313},{"date":"2024-01-19","current":13.874766,"twenty":12.449073,"median":15.447211,"eighty":23.720249,"marketCap":690352852},{"date":"2024-01-26","current":13.993227,"twenty":12.464948,"median":15.444987,"eighty":23.720022,"marketCap":696247007},{"date":"2024-02-02","current":14.096881,"twenty":12.506616,"median":15.444987,"eighty":23.720022,"marketCap":701404392},{"date":"2024-02-09","current":13.830343,"twenty":12.542803,"median":15.444987,"eighty":23.720022,"marketCap":688142544},{"date":"2024-02-16","current":14.511495,"twenty":12.58192,"median":15.444987,"eighty":23.720022,"marketCap":722033933},{"date":"2024-02-23","current":14.200534,"twenty":12.60569,"median":15.444987,"eighty":23.720022,"marketCap":706561777},{"date":"2024-03-01","current":14.237553,"twenty":12.653716,"median":15.44197,"eighty":23.719796,"marketCap":708403701},{"date":"2024-03-08","current":16.175481,"twenty":12.677591,"median":15.47025,"eighty":23.719796,"marketCap":790447218},{"date":"2024-03-15","current":15.745442,"twenty":12.714692,"median":15.544521,"eighty":23.719796,"marketCap":769432530},{"date":"2024-03-22","current":16.447084,"twenty":12.730066,"median":15.619791,"eighty":23.719796,"marketCap":803719653},{"date":"2024-03-28","current":17.518408,"twenty":12.743953,"median":15.66049,"eighty":23.719796,"marketCap":856072034},{"date":"2024-04-05","current":16.665875,"twenty":12.783006,"median":15.707587,"eighty":23.720022,"marketCap":814411336},{"date":"2024-04-12","current":16.431995,"twenty":12.794267,"median":15.723937,"eighty":23.720022,"marketCap":802982295},{"date":"2024-04-19","current":16.047224,"twenty":12.852789,"median":15.747568,"eighty":23.720022,"marketCap":784179679},{"date":"2024-04-26","current":16.620608,"twenty":12.875014,"median":15.792753,"eighty":23.719796,"marketCap":812199264},{"date":"2024-05-03","current":17.020469,"twenty":12.884793,"median":15.85372,"eighty":23.719796,"marketCap":831739237},{"date":"2024-05-10","current":16.225186,"twenty":12.903516,"median":15.890532,"eighty":23.719796,"marketCap":639174979},{"date":"2024-05-17","current":16.04585,"twenty":12.926829,"median":15.898654,"eighty":23.719796,"marketCap":632110218},{"date":"2024-05-24","current":14.55453,"twenty":12.942695,"median":15.898654,"eighty":23.719796,"marketCap":573361150},{"date":"2024-05-31","current":14.913202,"twenty":12.971918,"median":15.898654,"eighty":23.719796,"marketCap":587490673},{"date":"2024-06-07","current":14.894324,"twenty":12.979804,"median":15.898654,"eighty":23.719796,"marketCap":586747014},{"date":"2024-06-14","current":13.931573,"twenty":12.989258,"median":15.898654,"eighty":23.719796,"marketCap":548820401},{"date":"2024-06-21","current":13.251984,"twenty":13.001257,"median":15.901305,"eighty":23.720022,"marketCap":522048674},{"date":"2024-06-28","current":12.629028,"twenty":13.005614,"median":15.901305,"eighty":23.720022,"marketCap":497507924},{"date":"2024-07-05","current":11.826735,"twenty":13.005614,"median":15.901305,"eighty":23.720022,"marketCap":465902413},{"date":"2024-07-12","current":13.148158,"twenty":13.011006,"median":15.901305,"eighty":23.720022,"marketCap":517958549},{"date":"2024-07-19","current":13.705044,"twenty":13.035664,"median":15.901305,"eighty":23.720022,"marketCap":539896492},{"date":"2024-07-26","current":13.903257,"twenty":13.056304,"median":15.901305,"eighty":23.720022,"marketCap":547704912},{"date":"2024-08-02","current":13.710139,"twenty":13.09122,"median":15.901305,"eighty":23.720022,"marketCap":535627717},{"date":"2024-08-09","current":12.966991,"twenty":13.114826,"median":15.901305,"eighty":23.720022,"marketCap":506594386},{"date":"2024-08-16","current":13.643446,"twenty":13.118785,"median":15.901305,"eighty":23.720022,"marketCap":533022161},{"date":"2024-08-23","current":14.415178,"twenty":13.144172,"median":15.901305,"eighty":23.720022,"marketCap":563172158},{"date":"2024-08-30","current":14.567618,"twenty":13.181577,"median":15.901305,"eighty":23.720022,"marketCap":569127713},{"date":"2024-09-06","current":13.35762,"twenty":13.190654,"median":15.901305,"eighty":23.720022,"marketCap":521855496},{"date":"2024-09-13","current":13.100376,"twenty":13.190654,"median":15.901305,"eighty":23.720022,"marketCap":511805497},{"date":"2024-09-20","current":13.538643,"twenty":13.223691,"median":15.901305,"eighty":23.720022,"marketCap":528927717},{"date":"2024-09-27","current":13.243289,"twenty":13.2289,"median":15.901305,"eighty":23.720022,"marketCap":517388830},{"date":"2024-10-04","current":12.014236,"twenty":13.2289,"median":15.901305,"eighty":23.720022,"marketCap":469372168},{"date":"2024-10-11","current":12.338172,"twenty":13.2289,"median":15.901305,"eighty":23.720022,"marketCap":482027723},{"date":"2024-10-18","current":12.462031,"twenty":13.2289,"median":15.901305,"eighty":23.720022,"marketCap":486866611},{"date":"2024-10-25","current":11.652189,"twenty":13.2289,"median":15.901305,"eighty":23.720022,"marketCap":455227726},{"date":"2024-11-01","current":11.194867,"twenty":13.2289,"median":15.901305,"eighty":23.720022,"marketCap":437361061},{"date":"2024-11-08","current":29.194051,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":450843725},{"date":"2024-11-15","current":28.228958,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":435939800},{"date":"2024-11-22","current":26.853701,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":414701707},{"date":"2024-11-29","current":27.987685,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":432213819},{"date":"2024-12-06","current":28.590868,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":441528772},{"date":"2024-12-13","current":29.676597,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":458295687},{"date":"2024-12-20","current":27.505139,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":424761856},{"date":"2024-12-27","current":26.733065,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":412838716},{"date":"2025-01-03","current":26.467664,"twenty":13.243931,"median":15.919437,"eighty":23.769089,"marketCap":408740137},{"date":"2025-01-10","current":25.671463,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":396444399},{"date":"2025-01-17","current":28.30134,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":437057594},{"date":"2025-01-24","current":29.459451,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":454942304},{"date":"2025-01-31","current":29.049287,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":448608136},{"date":"2025-02-07","current":29.097541,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":449353332},{"date":"2025-02-14","current":29.097541,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":449353332},{"date":"2025-02-21","current":27.167356,"twenty":13.243717,"median":15.917117,"eighty":23.734878,"marketCap":419545483},{"date":"2025-02-28","current":26.443537,"twenty":13.243717,"median":15.917117,"eighty":23.781469,"marketCap":408367539},{"date":"2025-03-07","current":67.952097,"twenty":13.243503,"median":15.914797,"eighty":23.874977,"marketCap":489323047},{"date":"2025-03-14","current":66.191143,"twenty":13.243503,"median":15.914797,"eighty":23.954785,"marketCap":476642419},{"date":"2025-03-21","current":62.410272,"twenty":13.252615,"median":15.943232,"eighty":24.115722,"marketCap":449416366},{"date":"2025-03-28","current":61.63338,"twenty":13.257641,"median":15.958841,"eighty":24.177684,"marketCap":443821971},{"date":"2025-04-04","current":53.760881,"twenty":13.257641,"median":16.001956,"eighty":24.293229,"marketCap":387132106},{"date":"2025-04-11","current":50.394352,"twenty":13.260144,"median":16.034913,"eighty":24.374484,"marketCap":362889729},{"date":"2025-04-17","current":48.995948,"twenty":13.260144,"median":16.056126,"eighty":24.435695,"marketCap":352819819},{"date":"2025-04-25","current":53.346539,"twenty":13.257641,"median":16.111908,"eighty":24.514689,"marketCap":384148429},{"date":"2025-05-02","current":41.251143,"twenty":13.257641,"median":16.111908,"eighty":24.605959,"marketCap":433260752},{"date":"2025-05-09","current":43.422256,"twenty":13.276498,"median":16.118655,"eighty":24.70967,"marketCap":456063950},{"date":"2025-05-16","current":44.632384,"twenty":13.304211,"median":16.164277,"eighty":24.779878,"marketCap":468773929},{"date":"2025-05-23","current":43.49344,"twenty":13.305733,"median":16.214334,"eighty":24.92288,"marketCap":456811596},{"date":"2025-05-30","current":45.771328,"twenty":13.305733,"median":16.236896,"eighty":25.094599,"marketCap":480736262},{"date":"2025-06-06","current":48.084809,"twenty":13.305733,"median":16.263608,"eighty":25.328123,"marketCap":505034751},{"date":"2025-06-13","current":51.750787,"twenty":13.305733,"median":16.333916,"eighty":25.403214,"marketCap":543538511},{"date":"2025-06-20","current":51.715195,"twenty":13.304671,"median":16.39725,"eighty":25.527011,"marketCap":543164688},{"date":"2025-06-27","current":52.676179,"twenty":13.304671,"median":16.421562,"eighty":25.670494,"marketCap":553257906},{"date":"2025-07-01","current":51.572826,"twenty":13.304671,"median":16.429557,"eighty":25.69559,"marketCap":541669396}],"updateTime":1751477048807}}}